Digirad Corporation (DRAD) EPS Estimated At $0.03

July 18, 2017 - By Maria Brooks

 Digirad Corporation (DRAD) EPS Estimated At $0.03
Investors sentiment decreased to 1.16 in 2016 Q4. Its down 0.26, from 1.42 in 2016Q3. It is negative, as 7 investors sold Digirad Corporation shares while 12 reduced holdings. 8 funds opened positions while 14 raised stakes. 11.04 million shares or 6.33% more from 10.38 million shares in 2016Q3 were reported.
Renaissance Technologies Ltd Co holds 0.01% in Digirad Corporation (NASDAQ:DRAD) or 856,100 shares. Price T Rowe Associates Md stated it has 39,600 shares or 0% of all its holdings. Kennedy Capital holds 0.01% or 167,537 shares in its portfolio. Globeflex Limited Partnership reported 0% stake. Blackrock Institutional Trust Na accumulated 116,054 shares. Bridgeway Cap Mngmt, a Texas-based fund reported 241,794 shares. Walleye Trading Limited Com has 0% invested in Digirad Corporation (NASDAQ:DRAD). 397,210 were reported by Foundry Lc. Morgan Stanley owns 0% invested in Digirad Corporation (NASDAQ:DRAD) for 51,346 shares. Blackrock Fund Advsr holds 0% or 56,399 shares in its portfolio. Heartland Incorporated reported 0.25% stake. Jpmorgan Chase Communication holds 0% or 36,922 shares. Albion Group Incorporated Ut holds 13,100 shares. National Bank & Trust Of America De reported 34,081 shares. Punch And Assoc Management accumulated 0.62% or 1.25 million shares.

Analysts await Digirad Corporation (NASDAQ:DRAD) to report earnings on July, 27. They expect $0.03 EPS, down 66.67 % or $0.06 from last year’s $0.09 per share. DRAD’s profit will be $606,825 for 33.33 P/E if the $0.03 EPS becomes a reality. After $-0.01 actual EPS reported by Digirad Corporation for the previous quarter, Wall Street now forecasts -400.00 % EPS growth. About 422 shares traded. Digirad Corporation (NASDAQ:DRAD) has declined 28.44% since July 18, 2016 and is downtrending. It has underperformed by 45.14% the S&P500.

Digirad Corporation provides healthcare solutions. The company has market cap of $80.91 million. The Company’s divisions include Diagnostic Services, Mobile Healthcare, Diagnostic Imaging and Medical Device Sales and Services. It has a 136.99 P/E ratio. Through Diagnostic Services, the Company offers an imaging services program as an alternative to purchasing equipment or outsourcing the procedures to another physician or imaging center.

More notable recent Digirad Corporation (NASDAQ:DRAD) news were published by: Globenewswire.com which released: “Digirad Corporation Reports Financial Results for the First Quarter Ended …” on April 28, 2017, also Zacks.com with their article: “Digirad Corporation (DRAD) Looks Good: Stock Jumps 10% February 27, 2017” published on February 27, 2017, Globenewswire.com published: “Digirad Corporation to Present at the B. Riley and Company 18th Annual …” on May 09, 2017. More interesting news about Digirad Corporation (NASDAQ:DRAD) were released by: Seekingalpha.com and their article: “Digirad: A Growth Stock To Consider” published on December 15, 2016 as well as Globenewswire.com‘s news article titled: “Digirad Corporation Announces Closing of DMS Health Technologies Acquisition …” with publication date: January 05, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.